Previous 10 | Next 10 |
Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action Publication illustrates the power of stratifying PreTRM® testing risk at or above a threshold of twice the average population risk of spontaneous preterm birth (s...
Sera Prognostics Announces Collaboration To Help Underserved Communities Make Informed Decisions About Prenatal Health Partnership to include distribution of a children's book with essential prenatal healthcare information and support in the form of pregnancy/NICU "care boxes" ...
Sera Prognostics Announces Conference Call and Webcast of Third Quarter 2021 Financial Results on November 9 PR Newswire SALT LAKE CITY , Oct. 27, 2021 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving...
Brings extensive data science, bioinformatics and proteomics experience to foster further product innovation and informed healthcare insights into pregnancy SALT LAKE CITY, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: S...
SALT LAKE CITY, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that accordi...
SALT LAKE CITY, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Dr. Michael...
Publication illustrates clinical benefit of combining PreTRM ® testing with evidence-based interventions to improve neonatal health and reduce total health costs Positive impact on preterm births, neonatal intensive care admissions, overall hospital length of stay a...
SALT LAKE CITY, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the com...
This week’s Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking with George Ball, chairman of Sanders, Morris, Harris. Among the topics discussed: Stocks are expensive and the bull market is long in the tooth, but the Fed (or at least Chairman Jay Powell) is showi...
SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial res...
News, Short Squeeze, Breakout and More Instantly...
Sera Prognostics Inc. Company Name:
SERA Stock Symbol:
NASDAQ Market:
Sera Prognostics Inc. Website:
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA)...
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial PR Newswire Sera Prognostics Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-R...
2024-07-06 13:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...